Podiatrists in White Hall, AR Accepting Medicare

2 Podiatrists found. Showing 1 - 2

Dr. Scott Kevin Gray, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 8604 Dollarway Rd, White Hall, AR 71602 Phone: 870-536-3669    Fax: 870-536-0149

Scott K Gray Dpm Pa Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 8604 Dollarway Rd, White Hall, AR 71602 Phone: 870-536-3669    Fax: 870-536-0149

News Archive

WHO highlights global threat of NCDs, need for action at Moscow meeting

Non-communicable diseases are a "slow-moving catastrophe" that could overwhelm even the richest countries without action to address their underlying causes, WHO Director-General Margaret Chan said at the First Global Ministerial Conference on Healthy Lifestyles and Non-communicable Disease Control in Moscow on Thursday, the U.N. News Centre reports.

Sen. Pryor debuts campaign ad embracing health law provisions

The Arkansas Democrat, who is in a tough reelection fight, talked about his own struggle with cancer and how the health law provisions that prohibit insurance companies from denying coverage to people with medical problems could have helped him.

GP groups call for reinvestment into successful mental health program

United General Practice Australia – the coalition of the peak groups representing Australia's general practitioners – has issued a strong united statement calling on the government to expand the Better Access program to meet the demand for mental healthcare in the community rather than reducing Medicare patient rebates for vital mental health services.

Study finds abnormal alternative RNA splicing patterns in aggressive prostate cancer

Aggressive forms of prostate cancer don't act the way they should, hanging on to genetic materials called introns that should be thrown away, a new six-year study led by Dean Tang, Ph.D., and Song Liu, Ph.D., of Roswell Park Comprehensive Cancer Center has revealed.

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.

Read more Medical News

› Verified 3 days ago